G 319 (Ranolazine Extended-Release 500 mg)
Pill with imprint G 319 is Pink, Capsule-shape and has been identified as Ranolazine Extended-Release 500 mg. It is supplied by Glenmark Pharmaceuticals Inc..
Ranolazine is used in the treatment of angina and belongs to the drug class antianginal agents. Risk cannot be ruled out during pregnancy. Ranolazine 500 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for G 319
Ranolazine Extended-Release
- Imprint
- G 319
- Strength
- 500 mg
- Color
- Pink
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Antianginal agents
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Glenmark Pharmaceuticals Inc.
- National Drug Code (NDC)
- 68462-0319
Related Images for "G 319"
More about ranolazine
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 70 Reviews
- Drug class: antianginal agents
Consumer resources
Other brands: Ranexa
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
